Innovation prize for new drug against blood cancer

Innovation prize for new drug against blood cancer

This year, the Pharmazeutische Zeitung (PZ) signed to a 25. The most innovative drug of the year wit...
read more
Immunomedics Announces Publication of Triple-Negative Breast Cancer Data With Sacituzumab Govitecan in the New England Journal of Medicine

Immunomedics Announces Publication of Triple-Negative Breast Cancer Data With Sacituzumab Govitecan in the New England Journal of Medicine

MORRIS PLAINS, N.J., Feb. 20, 2019 (GLOBE NEWSWIRE...
read more
New England Journal of Medicine Publishes Positive Results of the Pivotal Trial of Cablivi (caplacizumab) for Rare Blood Clotting Disorder

New England Journal of Medicine Publishes Positive Results of the Pivotal Trial of Cablivi (caplacizumab) for Rare Blood Clotting Disorder

PARIS, Jan. 9, 2019 /PRNewswire/ — The New E...
read more